Global Japanese Encephalitis Vaccines Market Insights and Forecast to 2027

Epidemic encephalitis (JE) is a disease spreads through mosquito bites. Symptoms usually take 5-15 days to develop and include fever, headache, vomiting, confusion, and difficulty moving. The major form of the disease is encephalitis, and less severe forms such as aseptic meningitis or simple fever syndrome with headache are also frequent. The mortality rate of Japanese encephalitis is high, and sequelae are very common, especially among children (up to 50%). Prevention is possible through the use of inactivated vaccines.

Market Analysis and Insights: Global Japanese Encephalitis Vaccines Market
The global Japanese Encephalitis Vaccines market is valued at US$ XX million in 2019. The market size will reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.

Global Japanese Encephalitis Vaccines Scope and Market Size
Japanese Encephalitis Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Japanese Encephalitis Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Attenuated Vaccines
Inactivated Vaccines

Segment by Application
Adults
Children

By Company
Sanofi Pasteur
GlaxoSmithKline
Bharat Biotech
China National Biotec Group
Valneva Products

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia

Frequently Asked Questions